ELEM PinPoint mutation cell construction customized services and products LMKI-01/S05

To address the need for gene point mutations, ELEM provides CRISPR/Cas9-based gene editing services and supporting kits, enabling the creation of non-lethal point mutations in target genes in mammalian cells. The technology works as follows: Cas9 endonuclease and sgRNA form an RNP complex, which is then co-transfected into cells with a single-stranded oligodeoxynucleotide (ssODN) template.